We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Forgotten Vital Stain Identifies Resistant TB

By LabMedica International staff writers
Posted on 14 Aug 2012
Vital staining with fluorescein diacetate (FDA) stains only living Mycobacterium tuberculosis tuberculosis bacilli so that only those bacilli resistant to treatment are seen.

Scientists improved the detection of the luminous bacilli by replacing the classical fluorescence microscope with its light-emitting diode (LED) counterpart. More...
Together with colleagues in Bangladesh, scientists at the Antwerp Institute of Tropical Medicine (Belgium) tested the approach in the field for four years. If after treatment the FDA-test was negative, in 95% of cases more elaborate tests did not find active bacilli in the patient's sputum. And if the test was positive, a resistant bacillus had been found.

Tuberculosis bacilli that have become resistant to major antibiotics are a serious threat to world health. Checking smears under the microscope is the recommended technique for TB screening, but it cannot differentiate between living and dead bacilli. Therefore, it is not possible to know whether the bacilli observed are cadavers after a successful treatment, or resistant survivors. Only if the numbers do not decrease after a long wait, you know you are dealing with a resistant strain. But all that time the patient remains contagious.

With high-tech PCR technology, one can immediately ascertain if the bacillus is from a resistant strain, but in practice and certainly in resource-limited countries, this is unfeasible. It also is impossible to cultivate every sample and then bombard it with every possible antibiotic to survey which ones still work for that individual patient.

In 1991, a tuberculosis bug in New York was found to be resistant to 11 antibiotics. Cases have been reported where every antibiotic was useless. So far, these “omniresistant” bacilli each time perished with their host before they could spread. So far, that is. The highest numbers were all registered in the former Soviet Union.

Tuberculosis bacilli that have become resistant against the major antibiotics are a serious threat to world health.

To prevent an epidemic of difficult-to-treat tuberculosis, resistant cases, which do not react to the normal treatment, need to be recognized as early as possible, and immediately treated with second-line antibiotics that still work. But the laboratory tests to identify resistant TB bugs are cumbersome––the WHO estimates that in 2009 only 11% of multiresistant cases were discovered.

The FDA staining approach of Armand Van Deun and colleagues in the field for four years is very promising especially as it can be used in low-resource countries.

Related Links:
Antwerp Institute of Tropical Medicine
World Health Organization


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.